Dashboard
Manage Tickers

CGTX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cognition-therapeutics-announced-that-results-from-sequel-study-of-ct1812-the-companys-lead-candidate-for-alzheimers-disease-were-published-in-the-journal-of-prevention-of-alzheimers-disease
Cognition Therapeutics Announced That Resu...
08/22/2024 11:43:02

hc-wainwright--co-maintains-buy-on-cognition-therapeutics-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on Cogni...
08/12/2024 09:56:35

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and lowers the ...

cognition-therapeutics-q2-2024-gaap-eps-018-beats-024-estimate
Cognition Therapeutics Q2 2024 GAAP EPS $(...
08/08/2024 11:21:46

Cognition Therapeutics (NASDAQ:CGTX) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

b-riley-securities-downgrades-cognition-therapeutics-to-neutral-lowers-price-target-to-1
B. Riley Securities Downgrades Cognition T...
08/06/2024 17:21:00

B. Riley Securities analyst Mayank Mamtani downgrades Cognition Therapeutics (NASDAQ:CGTX) from Buy to Neutral and lowers th...

hc-wainwright--co-maintains-buy-on-cognition-therapeutics-lowers-price-target-to-7
HC Wainwright & Co. Maintains Buy on Cogni...
08/01/2024 10:25:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics (NASDAQ:CGTX) with a Buy and lowers the ...

cantor-fitzgerald-downgrades-cognition-therapeutics-to-neutral
Cantor Fitzgerald Downgrades Cognition The...
07/30/2024 09:51:48

Cantor Fitzgerald analyst Charles Duncan downgrades Cognition Therapeutics (NASDAQ:CGTX) from Overweight to Neutral.

dow-edges-lower-ventyx-biosciences-shares-plummet
Dow Edges Lower; Ventyx Biosciences Shares...
07/29/2024 18:31:47

why-bank-of-marin-bancorp-shares-are-trading-lower-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Bank of Marin Bancorp Shares Are Tradi...
07/29/2024 17:19:13

crude-oil-moves-lower-nls-pharmaceutics-shares-jump
Crude Oil Moves Lower; NLS Pharmaceutics S...
07/29/2024 16:03:54

cognition-therapeutics-stock-tumbles-on-mixed-data-from-mid-stage-alzheimers-study
Cognition Therapeutics Stock Tumbles On Mi...
07/29/2024 15:31:14

Cognition Therapeutics' Phase 2 'SHINE' study shows CT1812 leads to cognitive improvement in Alzheimer's patien...

nasdaq-gains-1-mcdonalds-posts-downbeat-results
Nasdaq Gains 1%; McDonald's Posts Downbeat...
07/29/2024 14:12:22

cognition-therapeutics-says-in-the-shine-study-ct1812-did-not-achieve-statistical-significance-on-the-first-of-the-ordered-secondary-efficacy-endpoints-in-the-pooled-100mg-and-300mg-dose-group-compared-to-placebo
Cognition Therapeutics Says 'In The SHINE ...
07/29/2024 11:58:48

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
07/29/2024 11:25:05

cognition-therapeutics-reports-phase-2-results-for-alzheimers-drug
Cognition Therapeutics Reports Phase 2 Res...
07/29/2024 11:05:13

Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing ...

trading-halt-halted-at-65500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 6:55:00 a.m. ET - ...
07/29/2024 10:55:03

why-pitney-bowes-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket
Why Pitney Bowes Shares Are Trading Higher...
07/29/2024 09:26:34

cognition-therapeutics-hosts-investor-webcast-to-discuss-results-from-phase-2-shine-study-of-ct1812-in-mild-to-moderate-alzheimers-disease-at-830am-et-on-monday-july-29-2024
Cognition Therapeutics Hosts Investor Webc...
07/26/2024 20:13:57

Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing ...

rodman--renshaw-reiterates-buy-on-cognition-therapeutics-maintains-14-price-target
Rodman & Renshaw Reiterates Buy on Cogniti...
07/02/2024 17:14:56

Rodman & Renshaw analyst Elemer Piros reiterates Cognition Therapeutics (NASDAQ:CGTX) with a Buy and maintains $14 price...

cognition-therapeutics-to-present-phase-2-shine-study-of-ct1812-in-mild-to-moderate-alzheimers-disease-at-alzheimers-associations-international-conference
Cognition Therapeutics to Present Phase 2 ...
07/02/2024 11:38:04

chardan-capital-initiates-coverage-on-cognition-therapeutics-with-buy-rating-announces-price-target-of-11
Chardan Capital Initiates Coverage On Cogn...
06/06/2024 20:38:08

Chardan Capital analyst Daniil Gataulin initiates coverage on Cognition Therapeutics (NASDAQ:CGTX) with a Buy rating and ann...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION